The Heart Speaks II

Ornish D Brown SE Scherwitz LW . Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990;336(8708):129-133.

Warber SL Ingerman S Moura VL . Healing the heart: a randomized pilot study of a spiritual retreat for depression in acute coronary syndrome patients. Explore (NY). 2011;7(4):222-233.

Meduri K Mullin G . Ayurvedic diets for wellness and disease intervention. Nutr Clin Pract. 2010;25(6):685-686.

Manchanda SC Narang R Reddy KS . Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Physicians India. 2000;48(7):687-694.

Pereira VH Cerqueira JJ Palha JA Sousa N . Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology [published ahead of print April 20, 2012]. Int J Cardiol.

Todini L Majorana M Luciani A Orso L . Depression and cardiovascular risk: relationship, pathogenetic mechanisms, treatment and patient management: a review of the literature [in Italian]. Clin Ter. 2012;163(2):e77-e84.

Hsia J Rodabough RJ Manson JE . Evaluation of the American Heart Association cardiovascular disease prevention guideline for women. Circ Cardiovasc Qual Outcomes. 2010;3(2):128-134.

Arthur HM Patterson C Stone JA . The role of complementary and alternative therapies in cardiac rehabilitation: a systematic evaluation. Eur J Cardiovasc Prev Rehabil. 2006;13(1):3-9.

Ornish D Scherwitz LW Billings JH . Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001-2007.

Kar S . Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects [published ahead of print October 4, 2011]. Am J Ther.

Rupp H Rupp TP Alter P Maisch B . Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in “HUFA deficiency.” Can J Physiol Pharmacol. 2012;90(1):55-73.

Wang MP Thomas GN Ho SY Lai HK Mak KH Lam TH . Fish consumption and mortality in Hong Kong Chinese—the LIMOR study. Ann Epidemiol. 2011;21(3):164-169.

Littarru GP Tiano L Belardinelli R Watts GF . Coenzyme Q(10), endothelial function, and cardiovascular disease. Biofactors. 2011;37(5):366-373.

Molyneux SL Florkowski CM George PM . Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol. 2008;52(18):1435-1441.

Belardinelli R Muçaj A Lacalaprice F Solenghi M Principi F Tiano L . Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors. 2005;25(1-4):137-145.

Pepe S Marasco SF Haas SJ Sheeran FL Krum H Rosenfeldt FL . Coenzyme Q10 in cardiovascular disease. Mitochondrion. 2007;7(suppl):S154-S167.

Langsjoen PH Langsjoen AM . Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors. 2008;32(1-4):119-128.

Ueland T Svardal A Oie E . Disturbed carnitine regulation in chronic heart failure: increased plasma levels of palmitoyl-carnitine are associated with poor prognosis [published ahead of print May 21, 2012]. Int J Cardiol.

Malaguarnera M . Carnitine derivatives: clinical usefulness. Curr Opin Gastroenterol. 2012;28(2):166-176.

Houston MC . The importance of potassium in managing hypertension. Curr Hypertens Rep. 2011;13(4):309-317.

Cunha AR Umbelino B Correia ML Neves MF . Magnesium and vascular changes in hypertension. Int J Hypertens. 2012;2012:754250.

Song Y Liu S . Magnesium for cardiovascular health: time for intervention. Am J Clin Nutr. 2012;95(2):269-270.

Mullin GE Greenson JK Mitchell MC . Fulminant hepatic failure after ingestion of sustained-release nicotinic acid. Ann Intern Med. 1989;111(3):253-255.

Gorinstein S Leontowicz H Leontowicz M . The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res. 2007;51(11):1365-1381.

Zalejska-Fiolka J Kasperczyk A Kasperczyk S Blaszczyk U Birkner E . Effect of garlic supplementation on erythrocytes antioxidant parameters, lipid peroxidation, and atherosclerotic plaque formation process in oxidized oil-fed rabbits. Biol Trace Elem Res. 2007;120(1-3):195-204.

Pittler MH Guo R Ernst E . Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev. 2008;(1):CD005312.

Mullin GE . Red wine, grapes, and better health—resveratrol. Nutr Clin Pract. 2011;26(6):722-723.

Willett WC . Dietary fats and coronary heart disease. J Intern Med. 2012;272(1):13-24. doi: 10.1111/j.1365-2796.2012.02553.x.PMID:2258305110.1111/j.1365-2796.2012.02553.x.PMID:22583051 [PubMed - in process]

Sabate J Wien M . Nuts, blood lipids and cardiovascular disease. Asia Pac J Clin Nutr. 2010;19(1):131-136.

Dreher ML . Pistachio nuts: composition and potential health benefits. Nutr Rev. 2012;70(4):234-240.

Ros E . Health benefits of nut consumption. Nutrients. 2010;2(7):652-682.

Jiang R Jacobs DR Jr Mayer-Davis E . Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2006;163(3):222-231.

Shang Q Liu Z Chen K Xu H Liu J . A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia. Evid Based Complement Alternat Med. 2012;2012:636547.

Slavin JL . Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108(10):1716-1731.

Huang J Frohlich J Ignaszewski AP . The impact of dietary changes and dietary supplements on lipid profile. Can J Cardiol. 2011;27(4):488-505.

Shukla SK Gupta S Ojha SK Sharma SB . Cardiovascular friendly natural products: a promising approach in the management of CVD. Nat Prod Res. 2010;24(9):873-898.

Ruiz-Canela M Martinez-Gonzalez MA . Olive oil in the primary prevention of cardiovascular disease. Maturitas. 2011;68(3):245-250.

Bohm V . Lycopene and heart health. Mol Nutr Food Res. 2012;56(2):296-303.

Bøhn SK Ward NC Hodgson JM Croft KD . Effects of tea and coffee on cardiovascular disease risk. Food Funct. March 29, 2012 [E-pub ahead of print].